GENE ONLINE|News &
Opinion
Blog

FDA
Trials & Approvals Hemophilia A
Sanofi’s Treatment for Hemophilia A has a Concrete FDA Decision Date
2022-08-30
Trials & Approvals Oncology
Incyte’s Rare Cancer Drug Snags Second FDA Approval
2022-08-29
COVID-19 FDA
FDA Removes N95 Respirators From the Medical Device Shortage List
2022-08-26
Trials & Approvals Pfizer
Pfizer’s Bivalent RSV Candidate Demonstrates 85% Efficacy in Phase 3 Trials
2022-08-26
Trials & Approvals Abbott Diagnostics Scarborough Inc.
FDA Approves Abbott’s Burst Stimulation Therapy For Chronic Pain
2022-08-25
Go Prime FDA
Mounting Criticisms of FDA’s Accelerated Approval Pathway Could Prompt Changes to the System
2022-08-25
Trials & Approvals Merck
Merck’s Anticoagulant Therapy Scores Fast Track Designation From FDA
2022-08-23
Trials & Approvals Kidney Disease
Ocelot’s Rare Kidney Disease Candidate Receives Orphan Drug Designation Going Into Phase 2 Trials
2022-08-23
Trials & Approvals Menopause
Astellas Pharmaceuticals’ Novel Non-hormonal Treatment for Severe Symptoms of Menopause Approved by the FDA
2022-08-18
Regulatory FDA
FDA Allows Sales of Over-the-Counter Hearing Aids After Five Years of Consideration
2022-08-17
Trials & Approvals Monkeypox
In Response to Expanding Monkeypox Outbreak, FDA Approves Emergency Use of JYNNEOS Vaccine
2022-08-11
Trials & Approvals Merck
FDA Finds Carcinogen In Merck’s Diabetes Drug, Allows Continued Sales To Avoid Shortage
2022-08-11
Trials & Approvals COPD
Verona’s COPD Candidate Scores Clinical Win, Paving the Way for FDA Submission
2022-08-10
M&A Pfizer
Pfizer Reportedly in Talks of $5 Billion Global Blood Therapeutics Purchase
2022-08-08
Trials & Approvals CancerClinical Trial
LOCOcyte – Avenge Bio’s Potential Treatment for Ovarian Cancer gets FDA Clearance
2022-08-03
1 2 3 4 5 6 … 24
LATEST
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top